Senegal vs Singapore: Proportion of the target population who received a 3rd dose of
Senegal
91.0%
in 2024
Singapore
91.0%
in 2024
Senegal rank
55th
Singapore rank
55th
Proportion of the target population who received a 3rd dose of over time
- Senegal
- Singapore
How they compare
Senegal currently reports 91.0% against 91.0% in Singapore, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2014 it was Senegal ahead.
Senegal ranks 55th and Singapore ranks 55th of 157 countries.
Across the 2 decades both report, Senegal averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Senegal | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.7% | 78.7% | 11.0% | Senegal |
| 2020s | 88.0% | 89.8% | 1.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Senegal or Singapore?
- Senegal, at 91.0% against 91.0% in Singapore as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Senegal and Singapore?
- 0.0%, with Senegal ahead.
- How many years of comparable data are there for Senegal and Singapore?
- 11 years are reported by both, from 2014 to 2024.
- How do Senegal and Singapore rank globally for proportion of the target population who received a 3rd dose of?
- Senegal ranks 55th and Singapore ranks 55th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.